Alert Indications, Safety, and Warnings

Vanta™ SCS Neurostimulator  Recharge-free spinal cord stimulation

Vanta™ SCS gives you an advantage over pain. This revolutionary recharge-free device offers optimized longevity, DTM™ SCS endurance programming, and unmatched MRI access.

Download Brochure
Close-up product image of the Vanta PC Neurostimulator on white background
Alert Indications, Safety, and Warnings

Overview

Your advantage
over pain

Learn about Vanta™ SCS.

Product details

High-performance recharge-free neurostimulator

Vanta™ SCS is a high-performance recharge-free device offering optimized longevity.

  • Approximately 2x longer lasting than other devices at comparable settings*†
  • 5½–7½ years of recharge-free longevity estimated using actual 12-month DTM™ SCS endurance therapy programming data1
Vanta Platform

DTM™ SCS endurance therapy

DTM™ SCS endurance therapy is an energy modified differential target multiplexed therapy offering meaningful pain relief, satisfaction, and quality of life improvements.2

SEE MORE EVIDENCE


Clinical evidence for DTM™ SCS endurance therapy2:

Meaningful pain reduction

↓4.6

cm reduction in VAS for overall
pain from baseline to 12-months

Quality of life improvements

76%

of patients improved in degree
of disability at 12-months

Therapy satisfaction

86%

of patients were
satisfied with therapy at 12-months

Unmatched full-body
MRI access

  • SureScan™ MRI technology allows MRI scans anywhere on the body‡ enabling diagnostic care.
  • Provide patients the same access as non-implanted patients‡ — now and in the future.
  • Shielded leads and proprietary device safeguards help patients safely get an MRI.‡
  • Access matters — 98% of patients are expected to need at least 1 MRI within 10 years of implant.3

Creating connections

The Medtronic adaptor extension connects with certain Boston Scientific™ or Nevro™ leads.§ This enables patients with existing leads to gain access to meaningful pain relief with DTM™ SCS endurance therapy offered with recharge-free convenience on Vanta™  INS.

Learn more

Product specifications

Compatible with:

  • MyStim™ PC smart patient therapy app model A72200
  • Clinician programmer model CT900 with software app A71200 and trialing app A71300
  • 16-electrode Specify™ SureScan™ MRI surgical leads
  • Vectris™ SureScan™ MRI percutaneous leads
  • INJEX™ anchoring system models 97791 and 97792

Model specifications

Model 977006 
Channels 2
Width 1.1 cm (.44in) 
Battery Type Recharge-free 

Contact us 

U.S. clinician services
800-707-0933

*

Settings used from Proclaim™ clinician manual. Nominal settings 12 hours per day: 50-Hz frequency. 225-μs pulse width, and 5-mA amplitude at 500-ohms impedance. Energy modeling is the same for model 3660 and model 3670.

†

Settings from Boston Scientific's Alpha™ IFU. Programmed at 4.1mA, 280us. 40Hz. 1 area, 730 Ohms, 2 contacts.

‡

Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.

§

Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

1

Provenzano, Amirdelfan, Grewal, et al. Modeling energy demands of a reduced-energy derivative of DTM™ stimulation on rechargeable and recharge-free SCS systems. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17–19, 2022; Orlando, FL, USA.

2

Provenzano, Peacock, Fishman, et al. A prospective multi-center study of a reduced-energy DTM™ stimulation derivative: Long-term outcomes in therapy naïve patients. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17–19, 2022; Orlando, FL, USA.

3

Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531–537